1. Home
  2. PHAR vs SSYS Comparison

PHAR vs SSYS Comparison

Compare PHAR & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.47

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Stratasys Ltd. (Israel)

SSYS

Stratasys Ltd. (Israel)

N/A

Current Price

$9.25

Market Cap

806.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PHAR
SSYS
Founded
1988
1989
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
806.5M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
PHAR
SSYS
Price
$16.47
$9.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$38.00
$12.75
AVG Volume (30 Days)
22.5K
767.5K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$362,274,000.00
$561,461,000.00
Revenue This Year
$24.80
N/A
Revenue Next Year
$6.84
$2.76
P/E Ratio
$2,946.57
N/A
Revenue Growth
26.78
N/A
52 Week Low
$7.50
$8.12
52 Week High
$18.12
$12.88

Technical Indicators

Market Signals
Indicator
PHAR
SSYS
Relative Strength Index (RSI) 54.85 49.64
Support Level $16.15 $8.91
Resistance Level $17.00 $9.40
Average True Range (ATR) 0.71 0.31
MACD -0.12 0.07
Stochastic Oscillator 58.01 43.37

Price Performance

Historical Comparison
PHAR
SSYS

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.

Share on Social Networks: